Everything You Should Understand About Skyward (SKWD) Rating Raised to Buy
Skyward Specialty Insurance Receives Zacks Rank Upgrade
Skyward Specialty Insurance (SKWD) has recently been elevated to a Zacks Rank #2 (Buy), reflecting a positive shift in its earnings outlook. This upgrade is largely driven by an upward trend in analysts’ earnings forecasts—a key factor that often influences stock prices.
Understanding the Zacks Rating System
The Zacks rating is based on changes in the Zacks Consensus Estimate, which aggregates earnings per share (EPS) projections from analysts covering the stock. As earnings expectations evolve, the Zacks system adjusts its ratings accordingly, providing individual investors with a data-driven tool to evaluate stocks. This approach can be more objective than relying solely on Wall Street analyst upgrades, which may be influenced by less transparent factors.
The recent upgrade for Skyward Specialty Insurance signals growing optimism about the company’s future earnings, which could attract more buyers and potentially drive the stock price higher.
Why Earnings Estimates Matter for Stock Prices
There is a strong link between changes in a company’s projected earnings and its stock price movements. Institutional investors often use these estimates to determine a stock’s fair value, and any adjustment in forecasts can lead to significant buying or selling activity. As a result, rising earnings estimates for Skyward suggest improvements in its core business, which investors may reward by bidding up the stock.
The Impact of Earnings Estimate Revisions
Research consistently shows that tracking revisions in earnings estimates can be a valuable strategy for investors. The Zacks Rank system leverages this insight by ranking stocks from #1 (Strong Buy) to #5 (Strong Sell) based on four key earnings-related factors. Since 1988, stocks rated Zacks Rank #1 have delivered an average annual return of 25%.
Skyward’s Earnings Outlook
Skyward Specialty Insurance, which operates in the property and casualty insurance sector, is projected to earn $4.73 per share for the fiscal year ending December 2026—unchanged from the previous year. However, analysts have become more optimistic, raising their consensus estimate for the company by 11.6% over the past three months.
Key Takeaways
The Zacks rating system stands out for its balanced approach, maintaining an even distribution of “buy” and “sell” ratings across more than 4,000 stocks. Only the top 5% receive a “Strong Buy” rating, while the next 15% are rated as “Buy.” Skyward’s placement in the top 20% of Zacks-covered stocks highlights its strong earnings estimate revisions, making it a compelling candidate for potential outperformance in the near future.
With its recent upgrade to Zacks Rank #2, Skyward Specialty Insurance is now among the top stocks in terms of positive estimate revisions, suggesting further upside could be ahead.
Zacks’ Top Stock Picks
Zacks’ research team has identified five stocks with the potential to double in value in the coming months. Among these, their Director of Research, Sheraz Mian, has spotlighted a lesser-known satellite communications company poised for significant growth as the space industry expands. While not every pick is a guaranteed winner, this selection could outperform previous high-flyers like Hims & Hers Health, which surged over 200%.
For more recommendations from Zacks Investment Research, you can download their report on the 7 Best Stocks for the Next 30 Days.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google reaches agreement with Epic Games, reduces Play Store commission fees to 20%

Reflecting on the fourth quarter earnings of financial technology stocks: Remitly (NASDAQ:RELY)

Reflecting on the fourth quarter earnings of financial technology stocks: Remitly (NASDAQ:RELY)


